Trial
NCT04406389
Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
COVID-19
Intervention
Enoxaparin sodium
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-21